NASDAQ:ADMA

ADMA Biologics SEC Filings & 10K Form

$1.65
-0.08 (-4.62 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$1.64
Now: $1.65
$1.71
50-Day Range
$1.67
MA: $2.00
$2.42
52-Week Range
$1.57
Now: $1.65
$4.20
Volume2.27 million shs
Average Volume3.54 million shs
Market Capitalization$200.10 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

SEC Filings

ADMA Biologics (NASDAQ:ADMA) SEC Filings

DateFilerForm TypeView
04/07/2021
4:30 PM
ADMA Biologics (Filer)
Form DEF 14A
03/01/2021
8:04 PM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:04 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:03 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:03 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:02 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:02 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:01 PM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
8:01 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:37 PM
ADMA Biologics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/16/2021
1:11 PM
ADMA Biologics (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/03/2021
4:01 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
4:01 PM
ADMA Biologics (Filer)
Form 424B5
02/01/2021
7:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/26/2021
7:31 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2021
7:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2020
3:46 PM
ADMA Biologics (Filer)
Form 8-A12B
12/16/2020
3:37 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
7:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
4:20 PM
ADMA Biologics (Filer)
Form 424B5
11/05/2020
4:16 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:37 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
7:00 AM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
7:00 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:01 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:00 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2020
7:00 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
7:00 AM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2020
7:01 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
7:02 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
7:02 AM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
7:01 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:23 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/06/2020
7:01 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
5:01 PM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:00 PM
ADMA Biologics (Issuer)
DEMSKI MARTHA J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
7:01 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
4:18 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2020
4:05 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
4:02 PM
ADMA Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/23/2020
7:30 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2020
3:10 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
6:12 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:11 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:11 PM
ADMA Biologics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:10 PM
ADMA Biologics (Issuer)
RICHMAN ERIC I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:10 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:09 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:08 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:08 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
6:07 PM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:17 AM
ADMA Biologics (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/13/2020
4:27 PM
ADMA Biologics (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13G/A
02/11/2020
9:18 AM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:16 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:15 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:13 AM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:11 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
7:02 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:18 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
6:18 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
4:29 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
4:11 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
6:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
6:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
6:49 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
11:15 PM
ADMA Biologics (Filer)
Form EFFECT
10/07/2019
3:11 PM
ADMA Biologics (Filer)
Form 424B7
10/07/2019
6:28 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
4:01 PM
ADMA Biologics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
7:08 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
6:29 AM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:08 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
3:48 PM
ADMA Biologics (Filer)
Form DEF 14A
07/08/2019
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
4:00 PM
ADMA Biologics (Filer)
Form PRE 14A
06/11/2019
7:22 PM
ADMA Biologics (Filer)
Form 8-K/A
06/07/2019
3:26 PM
ADMA Biologics (Subject)
Biotest Divestiture Trust (Filed by)
Form SC 13D/A
06/07/2019
3:25 PM
ADMA Biologics (Issuer)
Biotest Divestiture Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:01 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
7:32 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:31 AM
ADMA Biologics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
05/21/2019
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
6:14 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
6:13 AM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.